Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock

Serafina Valente1, Chiara Lazzeri, Sabine Vecchio

  • 1Coronary Care Unit, Heart and Vessel Department, Viale Morgagni 85, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy. seravalente@hotmail.com <seravalente@hotmail.com>

Insights

High mortality in cardiogenic shock (CS) following ST-elevation myocardial infarction (STEMI) is linked to elevated lactate levels. Hyperlactatemia on admission independently predicts in-hospital death in these critical patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Biochemistry

Background:

  • Cardiogenic shock (CS) complicating ST-elevation myocardial infarction (STEMI) carries a high mortality rate, even with timely revascularization.
  • Understanding CS pathophysiology has evolved beyond hemodynamics to include metabolic dysregulation.
  • Predictors of mortality in CS post-STEMI require further elucidation.

Purpose of the Study:

  • To identify predictors of in-hospital mortality in patients with CS complicating STEMI.
  • To investigate the role of serum lactate, glucose, and uric acid levels in predicting outcomes.

Main Methods:

  • A cohort of 45 consecutive patients with CS complicating STEMI treated with primary percutaneous coronary intervention (PCI) was studied.
  • Serum levels of lactate, glucose, and uric acid were measured upon coronary care unit (CCU) admission.
  • In-hospital death was the primary endpoint.

Main Results:

  • Univariate predictors of mortality included elevated glucose, creatinine, uric acid, lactate, older age, hypertension, and poor TIMI flow post-PCI.
  • Multivariate analysis identified hyperlactatemia (>6.5 mmol/l) and TIMI flow post-PCI ≤2 as independent predictors of in-hospital death.
  • Hyperlactatemia showed a significantly higher odds ratio (OR=295, p=0.01) for mortality.

Conclusions:

  • Hyperlactatemia, hyperglycemia, and elevated uric acid are univariate predictors of in-hospital death in CS patients post-STEMI.
  • Hyperlactatemia (>6.5 mmol/l) emerges as a robust, independent predictor of in-hospital mortality in this high-risk population.
  • These metabolic markers can aid in risk stratification and management decisions.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...